Rare Oncology

Five headwinds facing rare cancer drug developers (and what to do about it)

Moderator:
Benjamin Brown, Executive Director, American Society of Pharmacovigilance

Mridula Shukla, Head of Regulatory Affairs, Gene Therapy, Poseida Therapeutics, Inc.

Jim Palma, Chief Executive Officer, TargetCancer Foundation

Winning approaches for rare disease patient recruitment

Discover Effective Tactics and Methods for Rare Disease Patient Recruitment Campaigns, Drawing from Real-World Case Studies, Examples, and Best Practices to Ensure Enrollment Success in Studies.

Matt Teuteberg, President/ CEO, Splash Clinical

Teri Hagemann, Director of Client Services, Splash Clinical